1
Clinical Trials associated with Anti-GFRA4 CAR-T (University of Pennsylvania)Phase I Trial of GFRα4 CAR T Cells in Adult Patients With Recurrent or Metastatic Medullary Thyroid Cancer
This is an open-label phase 1 study to assess the safety and feasibility of autologous T cells expressing a single-chain scFv targeting GFRα4 with tandem TCR/CD3ζ and 4-1BB (TCRζ/4-1BB) co-stimulatory domains (referred to as "CART-GFRa4 cells") in patients with incurable medullary thyroid cancer (MTC).
100 Clinical Results associated with Anti-GFRA4 CAR-T (University of Pennsylvania)
100 Translational Medicine associated with Anti-GFRA4 CAR-T (University of Pennsylvania)
100 Patents (Medical) associated with Anti-GFRA4 CAR-T (University of Pennsylvania)
100 Deals associated with Anti-GFRA4 CAR-T (University of Pennsylvania)